No Result
View All Result
  • Home
  • Stock Watchlist
  • Stock Analyst News
  • Earnings News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
techstockmovers.com
No Result
View All Result

1 Stock Make It On Today's Healthcare & Biotech Stock Watchlist

by Staff Editor
Jun 01, 2023
in Health Watchlist healthcare stocks 

 Powered by HealthTechMovers.com

We added 1 stock to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.

In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention.  This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.

If you have other stocks that you are researching, then you need to Join TipRanks.com Now to get insights on every stock being traded!


Catalyst Pharma, CPRX
Summary: Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights to Firdapse (for treating LEMS) from BioMarin Pharmaceutical Inc. for its development and commercialization in the U.S. Firdapse is currently approved in the European Union and in the U.S. for treating of LEMS in adults. The company also plans to file a supplemental new drug application for Firdapse to treat pediatric patients with LEMS.'The company is also strengthening the commercial portfolio of Firdapse. It has already received multiple patents that cover the treatment of all amifampridine metabolizer types within the LEMS patient population.'Apart from Firdapse, the company is working on a generic version of Lundbeck's Sabril, CPP-109, for the treatment of infantile spasms and complex partial seizures.
  • Last Price: $11.64
  • Price Change: $0.09, 0.78%
  • Yearly Gain: 62.68%
  • Market Cap: $1.23B
  • P/E Ratio: 13.055

Here are 3rd party ratings for CPRX:

  • TipRanks.com: Strong Buy
  • TradingView.com: Neutral
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Strong Sell, Top 43% (108 out of 250)

What is the sentiment on the street regarding Catalyst Pharma ?  (Current ratings compiled by TipRanks.com)

  • News Sentiment: Very Bullish
  • Blogger Consensus: Bullish
  • Media Buzz: Medium
  • Insider Signal: Neutral
  • Investor Sentiment: Positive
  • Hedge Fund signal: Very Positive

If you are interested in CPRX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CPRX before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------


Thanks for reading!
Tags: healthcare stocks Healthcare stock watchlist Healthcare movers Catalyst Pharma stock CPRX 

Related Posts

technology stocks Technology stock movers ENVX ENVX price target Enovix stock 

Craig-Hallum Analyst Reiterates Buy Rating on Enovix, ENVX Stock

Oct 03, 2023
technology stocks Technology stock movers NVDA NVDA price target Nvidia stock 

KeyBanc Analyst Reiterates Buy Rating on Nvidia, NVDA Stock

Oct 03, 2023
technology stocks Technology stock movers Technology stock watchlist tech stocks tech stock analyst ratings 

Craig-Hallum Analyst Reiterates Buy Rating on Genius Sports Limited, GENI Stock

Oct 03, 2023
technology stocks Technology stock movers Technology stock watchlist tech stocks Kinaxis Inc stock 

Canaccord Genuity Analyst Reiterates Buy Rating on Kinaxis Inc, KXSCF Stock

Oct 03, 2023
technology stocks Technology stock movers Technology stock watchlist tech stocks CDW stock 

Citi Analyst Reiterates Buy Rating on CDW, CDW Stock

Oct 03, 2023
technology stocks Technology stock movers Technology stock watchlist tech stocks tech stock analyst ratings 

Northland Securities Analyst Reiterates Buy Rating on SPS Commerce, SPSC Stock

Oct 03, 2023
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Sitemap
  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Privacy Policy
  • Disclaimer

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In